305 related articles for article (PubMed ID: 22451450)
1. Superiority of long-acting to short-acting loop diuretics in the treatment of congestive heart failure.
Masuyama T; Tsujino T; Origasa H; Yamamoto K; Akasaka T; Hirano Y; Ohte N; Daimon T; Nakatani S; Ito H
Circ J; 2012; 76(4):833-42. PubMed ID: 22451450
[TBL] [Abstract][Full Text] [Related]
2. Changes in brain natriuretic peptide in chronic heart failure patients treated with long-acting versus short-acting loop diuretics: J-MELODIC subanalysis.
Fukui M; Tsujino T; Hirotani S; Ito H; Yamamoto K; Akasaka T; Hirano Y; Ohte N; Daimon T; Nakatani S; Kawabata M; Masuyama T
Heart Vessels; 2017 Jul; 32(7):865-871. PubMed ID: 28105515
[TBL] [Abstract][Full Text] [Related]
3. Patients With CONgestive Heart Failure Benefit From Long-Term Treatment Effects With Novel Treatment Using Azosemide Compared With Furosemide Derived From Existing Retrospective Study Data: CONTENTED.
Toyoda S; Arikawa T; Inami S; Nishikawa R; Saito F; Watanabe R; Sakuma M; Kanaya T; Abe S; Inoue T
J Cardiovasc Pharmacol; 2019 Jun; 73(6):365-372. PubMed ID: 31162245
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of therapeutic effects of short- and long-acting loop diuretics in outpatients with chronic heart failure (COLD-CHF).
Miyata M; Sasaki T; Ikeda Y; Shinsato T; Kubozono T; Furusho Y; Kusumoto A; Hamasaki S; Tei C;
J Cardiol; 2012 May; 59(3):352-8. PubMed ID: 22365947
[TBL] [Abstract][Full Text] [Related]
5. Rationale and design of a randomized trial to assess the effects of diuretics in heart failure: Japanese Multicenter Evaluation of Long- vs Short-Acting Diuretics in Congestive Heart Failure (J-MELODIC).
J-MELODIC Program Committee
Circ J; 2007 Jul; 71(7):1137-40. PubMed ID: 17587724
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of the therapeutic effects of long-acting and short-acting loop diuretics in the treatment of chronic heart failure using (123)I-metaiodobenzylguanidine scintigraphy.
Hisatake S; Nanjo S; Fujimoto S; Yamashina S; Yuzawa H; Namiki A; Nakano H; Yamazaki J
Eur J Heart Fail; 2011 Aug; 13(8):892-8. PubMed ID: 21602550
[TBL] [Abstract][Full Text] [Related]
7. Comparative Analysis of Long-Term Outcomes of Torasemide and Furosemide in Heart Failure Patients in Heart Failure Registries of the European Society of Cardiology.
Ozierański K; Balsam P; Kapłon-Cieślicka A; Tymińska A; Kowalik R; Grabowski M; Peller M; Wancerz A; Marchel M; Crespo-Leiro MG; Maggioni AP; Drożdż J; Filipiak KJ; Opolski G
Cardiovasc Drugs Ther; 2019 Feb; 33(1):77-86. PubMed ID: 30649675
[TBL] [Abstract][Full Text] [Related]
8. Comparison of neurohumoral effects of short-acting and long-acting loop diuretics in patients with chronic congestive heart failure.
Tsutsui T; Tsutamoto T; Maeda K; Kinoshita M
J Cardiovasc Pharmacol; 2001 Oct; 38 Suppl 1():S81-5. PubMed ID: 11811366
[TBL] [Abstract][Full Text] [Related]
9. Effects of short-acting and long-acting loop diuretics on heart rate variability in patients with chronic compensated congestive heart failure.
Tomiyama H; Nakayama T; Watanabe G; Shiojima K; Sakuma Y; Yamamoto A; Imai Y; Yoshida H; Doba N
Am Heart J; 1999 Mar; 137(3):543-8. PubMed ID: 10047639
[TBL] [Abstract][Full Text] [Related]
10. Different effects of long- and short-acting loop diuretics on survival rate in Dahl high-salt heart failure model rats.
Yoshida J; Yamamoto K; Mano T; Sakata Y; Nishio M; Ohtani T; Hori M; Miwa T; Masuyama T
Cardiovasc Res; 2005 Oct; 68(1):118-27. PubMed ID: 16002057
[TBL] [Abstract][Full Text] [Related]
11. Comparative effects of long and short-acting loop diuretics on mortality in patients with chronic heart failure.
Kasama S; Toyama T; Kurabayashi M
Int J Cardiol; 2017 Oct; 244():242-244. PubMed ID: 28645802
[TBL] [Abstract][Full Text] [Related]
12. Use of short-acting vs. long-acting loop diuretics after heart failure hospitalization.
Imaeda S; Shiraishi Y; Kohsaka S; Niimi N; Goda A; Nagatomo Y; Takei M; Saji M; Nakano S; Kohno T; Fukuda K; Yoshikawa T
ESC Heart Fail; 2022 Oct; 9(5):2967-2977. PubMed ID: 35730147
[TBL] [Abstract][Full Text] [Related]
13. The impact of torasemide on haemodynamic and neurohormonal stress, and cardiac remodelling in heart failure - TORNADO: a study protocol for a randomized controlled trial.
Balsam P; Ozierański K; Tymińska A; Główczyńska R; Peller M; Fojt A; Cacko A; Sieradzki B; Bakuła E; Markulis M; Kowalik R; Huczek Z; Filipiak KJ; Opolski G; Grabowski M
Trials; 2017 Jan; 18(1):36. PubMed ID: 28114980
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Long-Acting and Short-Acting Loop Diuretics in the Treatment of Heart Failure With Preserved Ejection Fraction.
Suzuki S; Motoki H; Kanzaki Y; Maruyama T; Hashizume N; Kozuka A; Yahikozawa K; Kuwahara K
Circ Rep; 2019 Feb; 1(3):137-141. PubMed ID: 33693128
[No Abstract] [Full Text] [Related]
15. Comparative effectiveness of torasemide versus furosemide in symptomatic therapy in heart failure patients: Preliminary results from the randomized TORNADO trial.
Balsam P; Ozierański K; Marchel M; Gawałko M; Niedziela Ł; Tymińska A; Sieradzki B; Sieradzki M; Fojt A; Bakuła E; Główczyńska R; Peller M; Markulis M; Bednarski J; Kowalik R; Cacko A; Niewiński G; Filipiak KJ; Opolski G; Grabowski M
Cardiol J; 2019; 26(6):661-668. PubMed ID: 31909470
[TBL] [Abstract][Full Text] [Related]
16. Torsemide versus furosemide and intermediate-term outcomes in patients with heart failure: an updated meta-analysis.
Miles JA; Hanumanthu BK; Patel K; Chen M; Siegel RM; Kokkinidis DG
J Cardiovasc Med (Hagerstown); 2019 Jun; 20(6):379-388. PubMed ID: 30950982
[TBL] [Abstract][Full Text] [Related]
17. Comparative effectiveness of loop diuretics on mortality in the treatment of patients with chronic heart failure - A multicenter propensity score matched analysis.
Täger T; Fröhlich H; Grundtvig M; Seiz M; Schellberg D; Goode K; Kazmi S; Hole T; Katus HA; Atar D; Cleland JGF; Agewall S; Clark AL; Frankenstein L
Int J Cardiol; 2019 Aug; 289():83-90. PubMed ID: 30827731
[TBL] [Abstract][Full Text] [Related]
18. Impact of short-acting loop diuretic doses and cardiac sympathetic nerve abnormalities on outcomes of patients with reduced left ventricular function.
Onitsuka H; Koyama S; Ideguchi T; Ishikawa T; Kitamura K; Nagamachi S
Medicine (Baltimore); 2019 Feb; 98(8):e14657. PubMed ID: 30813209
[TBL] [Abstract][Full Text] [Related]
19. Diuretic therapy as prognostic enrichment factor for clinical trials in patients with heart failure with reduced ejection fraction.
Coiro S; Girerd N; McMurray JJV; Pitt B; Swedberg K; van Veldhuisen DJ; Lamiral Z; Rossignol P; Zannad F
Clin Res Cardiol; 2021 Aug; 110(8):1308-1320. PubMed ID: 33956209
[TBL] [Abstract][Full Text] [Related]
20. Effect of adding nitroglycerin to early diuretic therapy on the morbidity and mortality of patients with chronic kidney disease presenting with acute decompensated heart failure.
Aziz EF; Kukin M; Javed F; Pratap B; Sabharwal MS; Tormey D; Frankenberger O; Herzog E
Hosp Pract (1995); 2011 Feb; 39(1):126-32. PubMed ID: 21441767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
